Drugs (Pharmaceuticals) – Page 39

F.D.A. Advisers Say Benefits of Over-the-Counter Birth Control Pill Outweigh Risks

The agency is expected to decide this summer whether to allow the first nonprescription sales of an oral contraceptive in the United States.

By Pam Belluck

Birth Control and Family Planning Drugs (Pharmaceuticals) Food and Drug Administration Gynecology and Gynecologists HRA Pharma Medicine and Health Perrigo Company Teenagers and Adolescence Women and Girls

F.D.A. Advisers Weigh Allowing First U.S. Over-the-Counter Birth Control Pill

The panel heard strong support from the company and many doctors but concern from F.D.A. scientists.

By Pam Belluck

Centers for Disease Control and Prevention Compensation for Damages (Law) Decisions and Verdicts Drugs (Pharmaceuticals) Gilead Sciences Inc Health and Human Services Department Inventions and Patents Suits and Litigation (Civil)

U.S. Loses Key Case on Rights to H.I.V.-Prevention Drugs

In an unusual court trial, a federal jury sided with the drug maker Gilead Sciences in a dispute over who came up with the idea of using a daily pill to prevent H.I.V.

By Rebecca Robbins

Brain Drugs (Pharmaceuticals) Eli Lilly and Company Research

Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease

Donanemab is not a cure and comes with significant side effects, but patients had longer periods of independent living while on the drug.

By Gina Kolata

mosaec